Close
CDMO Safety Testing 2026
Novotech

Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Sigma Healthcare Pursues Potential Boots Acquisition Deal

Australiaโ€™s Sigma Healthcare has confirmed that it is participating...

MHRA Launches AI Sandbox to Accelerate Drug Development

The Medicines and Healthcare products Regulatory Agency (MHRA) has...

Pfizer’s Hympavzi Wins FDA Expanded Approval for Haemophilia A and B

Pfizer has secured an expanded indication approval from the...
- Advertisement -

Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Ian Read, Chairman and CEO at the Bernstein 32nd Annual Strategic Decisions Conference on Thursday, June 2, 2016 at 2:00 p.m. Eastern Daylight Time.

To listen to the webcast, visit our web site at www.pfizer.com and click on the โ€œBernstein 32nd Annual Strategic Decisions Conferenceโ€ link in the For Investors section located on the lower right-hand corner of that page.

Information on accessing and pre-registering for the webcast will be available at www.pfizer.com beginning today.

Visitors will be able to listen to an archived copy of the webcast at www.pfizer.com.

Contact:

Joan Campion,
212-733-2798

Investor:

Bryan Dunn, 212-733-8917

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Sigma Healthcare Pursues Potential Boots Acquisition Deal

Australiaโ€™s Sigma Healthcare has confirmed that it is participating...

MHRA Launches AI Sandbox to Accelerate Drug Development

The Medicines and Healthcare products Regulatory Agency (MHRA) has...

Pfizer’s Hympavzi Wins FDA Expanded Approval for Haemophilia A and B

Pfizer has secured an expanded indication approval from the...

Incyte Expands Haematology Portfolio with Vega Acquisition

Incyte has agreed to acquire Vega Therapeutics, a subsidiary...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป